Although it is unclear what this increased risk is due to, Waked et al47 hypothesised that it may be due to a stimulatory effect of hormonal therapy on the communication between breast cancer cells and ADSCs or more worryingly that hormone receptor–positive patients with breast cancer may be at increased risk of LRR post-autologous grafting. This evidence concerns the gene NR4A1 and breast carcinoma.